Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn disease
We report a multiomics analysis of the gut microbiota and fecal/blood metabolites of 278 CD patients and 28 healthy controls, providing the most comprehensive profile to date of specific microbes and metabolites associated with intestinal fibrosis.